Comparison of Two Toric Contact Lenses on Current Toric Wearers

May 5, 2015 updated by: Johnson & Johnson Vision Care, Inc.

A Multi-Center, Subject Masked, Randomized, Two Week Crossover Design, Investigation of the Acuvue Cypress Toric Silicone Hydrogel Lens Compared to the Bausch & Lomb SofLens66® Toric Hydrophilic Lens

The purpose of this study is to evaluate and compare the clinical performance of two toric contact lenses amongst 110 subjects, 2-week, single masked (subject), daily wear, randomized, bilateral, crossover study; 4 weeks duration. Hypotheses include equal or better performance of the test lens over the control lenses for comfort, vision, and toric fit characteristics as well as corneal integrity

Study Overview

Status

Completed

Conditions

Detailed Description

Up to 7 sites in the US will participate. Each investigator will have both test and control lens types. There will be a maximum of 6 scheduled visits:

Visit 1: Habitual lens evaluation / Baseline / Trial fitting Visit 2: Dispensing (to be combined with Visit 1 where possible), Visit 3: Questionnaire only (no exam) 7 days (±2) after dispensing, Visit 4: 2 week follow-up 14 days (±3) after dispensing, and dispense second lens type, Visit 5: Questionnaire only (no exam) 7 days (±2) after 2nd lens dispense, Visit 6: 2 week follow-up 14 days (±3) after 2nd lens dispense

Study Type

Interventional

Enrollment (Actual)

89

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Jacksonville, Florida, United States, 32256
        • Ted Brink and Associates
      • Orlando, Florida, United States, 32801
        • Eola Eyes
    • Georgia
      • Morrow, Georgia, United States, 30260
        • Clayton Eye Center
    • Missouri
      • St Louis, Missouri, United States, 63144
        • The Koetting Associates Inc.
    • North Carolina
      • Concord, North Carolina, United States, 28025
        • Southern Eyes
    • Ohio
      • Beachwood, Ohio, United States, 44122
        • Western Reserve Vision Care
    • Tennessee
      • Brentwood, Tennessee, United States, 37027
        • Primary Eyecare Group, P.C.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Be at least 18 and less than or equal to 45 years of age, have a need for vision correction and wear contact lenses in BOTH eyes (monovision or uni-ocular fitting is NOT allowed).
  2. Be able to read J1 at near WITHOUT the aid of a near addition over the distance prescription.
  3. Be a currently successful wearer for at least 3 months of B&L SofLens 66 Toric hydrogel lenses.
  4. Be able and willing to adhere to the instructions set forth in the protocol.
  5. Agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
  6. Have a distance spectacle spherical component between -1.00 D and -5.25 D with cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 30° of the horizontal in both eyes (when the subject's prescription is presented in minus cylinder form).
  7. Have a best corrected manifest refraction visual acuity of at least 20/25 or better in each eye.
  8. Be in good general health, based on his/her knowledge.
  9. Must be given an explanation of the study objectives, lens and solutions usage requirements and visit schedule. The subject must read, indicate understanding of and agree to begin participation in the clinical study. The subject must then sign the Informed Consent Form in the presence of the Investigator or their designee.

Exclusion Criteria:

  1. Presbyopic or has the need for a near add for reading.
  2. Previous refractive surgery; current or previous orthokeratology treatment.
  3. Aphakia, keratoconus or a highly irregular cornea.
  4. The presence of ocular or systemic disease or has the need for medication (ocular or systemic) which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (e.g., Sjögren's syndrome, type II diabetes, allergies).
  5. A known history of corneal hypoesthesia (reduced corneal sensitivity.)
  6. Anterior uveitis or iritis (past or present).
  7. A history of recurrent erosions, corneal infiltrates corneal ulcer or fungal infections.
  8. Clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations or infections of the eye, eyelids, or associated structures.
  9. Slit lamp findings that would contraindicate contact lens wear such as:

    • Pathological dry eye or associated findings
    • Pterygium or corneal scars within the visual axis
    • Neovascularization >1mm in from the limbus
    • History of giant papillary conjunctivitis (GPC) worse than Grade 2
    • Meibomian gland dysfunction, blepharitis, or seborrhoeic dermatitis
  10. Current pregnancy or lactation (to the best of the subject's knowledge).
  11. Actively participating in another clinical study at any time during this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: senofilcon A
senofilcon A toric daily wear contact lenses
silicone hydrogel toric lens, 2 wk replacement, daily wear
Other Names:
  • ACUVUE OASYS
Active Comparator: alphafilcon A
alphafilcon A toric daily wear contact lenses
hydrogel toric lens, 2 wk replacement, daily wear
Other Names:
  • SofLens Toric

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lens Orientation Within 5 Degrees
Time Frame: 1 minute after insertion
Number of eyes with lens orientation within 5 degrees of optimal orientation within 1 minute of contact lens insertion.
1 minute after insertion
Lens Stability
Time Frame: 10-15 minutes after insertion
Number of eyes with the amount of rotation induced from a blink within 5 degrees of settled orientation.
10-15 minutes after insertion
Subjective Lens Comfort
Time Frame: 1 and 2 weeks
A weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the difference in outcome between the test and control. >0=comfortable, <0=uncomfortable.
1 and 2 weeks
Subjective Vision
Time Frame: 1 and 2 weeks
A weighted combined score calculated from individual vision-related questions asked on a 1-5 scale: 1=most negative response to 5=most positive response, was used to derive vision outcomes. The analysis shows the difference in outcome between the test and control. >0=satisfactory vision, <0=unsatisfactory vision.
1 and 2 weeks
Overall Corneal Staining
Time Frame: after 2 weeks use
Corneal staining measured using the National Eye Institute grading scale of grade 0 = normal, grade 1 = mild, grade 2 = moderate, grade 3 = severe.
after 2 weeks use

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2008

Primary Completion (Actual)

June 1, 2008

Study Completion (Actual)

June 1, 2008

Study Registration Dates

First Submitted

March 13, 2008

First Submitted That Met QC Criteria

March 19, 2008

First Posted (Estimate)

March 20, 2008

Study Record Updates

Last Update Posted (Estimate)

May 21, 2015

Last Update Submitted That Met QC Criteria

May 5, 2015

Last Verified

May 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CR-0802

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ametropia

Clinical Trials on senofilcon A toric

Subscribe